Published in Digestion on January 01, 2001
Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest (2001) 2.35
Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ (1999) 2.28
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol (2001) 1.84
Laparoscopic-assisted resection of giant sigmoid lipoma under colonoscopic guidance. Surg Endosc (2002) 1.66
Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (1999) 1.60
Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest (1999) 1.44
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
[Megaloblastic anemia due to inadequate nutrition]. Dtsch Med Wochenschr (1997) 1.39
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut (2005) 1.30
A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol (2002) 1.28
Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol (2004) 1.23
The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 1.20
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology (1992) 1.19
Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol (2004) 1.16
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology (1995) 1.14
Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl (1989) 1.07
MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens (2001) 1.05
Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction. Endoscopy (2004) 1.05
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med (1988) 1.01
Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol (2001) 1.00
Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 0.96
Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology (1997) 0.95
Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol (2003) 0.94
Gastrointestinal intramural hematoma, a complication of endoscopic injection methods for bleeding peptic ulcers: a case series. Endoscopy (1994) 0.93
Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion (2004) 0.92
Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion (2002) 0.91
Influence of prophylactic local administration of epinephrine on bleeding complications after polypectomy. Endoscopy (1997) 0.88
Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion (2000) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
Klippel-Trenaunay syndrome with involvement of coecum and rectum: a rare cause of lower gastrointestinal bleeding. Eur J Med Res (2004) 0.88
Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun (2001) 0.88
n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci (1996) 0.87
The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis (2000) 0.87
The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2001) 0.86
A prospective study of serum ghrelin levels in patients treated with clozapine. J Neural Transm (Vienna) (2005) 0.86
The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin. Clin Immunol (2003) 0.86
[Blue rubber-bleb nevus syndrome and therapeutic double balloon enteroscopy]. Z Gastroenterol (2006) 0.86
Lower esophageal sphincter pressure in patients with gastroesophageal reflux diseases and posture and time patterns. Dis Esophagus (2004) 0.86
The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin Immunol (2003) 0.83
Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology (2005) 0.83
Adoptive transfer of genetic susceptibility to Crohn's disease. Gut (2004) 0.83
Post-prandial decrease of human plasma ghrelin in the absence of insulin. J Endocrinol Invest (2003) 0.82
Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux. J Laryngol Otol (2004) 0.82
Rosacea fulminans in a patient with Crohn's disease: a case report and review of the literature. Acta Derm Venereol (2000) 0.81
Age dependency of intrarenal resistance index (RI) in healthy adults and patients with fatty liver disease. Eur J Med Res (2007) 0.81
Regulation of ghrelin is related to estimated insulin sensitivity in obese children. Int J Obes (Lond) (2006) 0.80
Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism. Digestion (2003) 0.80
Score card endoscopy: a multicenter study to evaluate learning curves in 1-week courses using the Erlangen Endo-Trainer. Endoscopy (2003) 0.79
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Aliment Pharmacol Ther (2009) 0.79
Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. Eur J Med Res (2005) 0.79
Search for mumps virus genome in intestinal biopsy specimens of patients with IBD. Gastroenterology (1999) 0.79
Intrarenal resistance index for the assessment of early renal function impairment in patients with liver cirrhosis. Eur J Med Res (2008) 0.79
K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease. Scand J Gastroenterol (2002) 0.79
A polymorphism in the IL11 gene is associated with ulcerative colitis. Genes Immun (2002) 0.79
The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease. Dig Liver Dis (2004) 0.79
Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives. Dig Dis Sci (1997) 0.78
Effectiveness of a novel endoscopy training concept. Endoscopy (2011) 0.78
[Alternative sonographic determination of liver size by intercostal scans]. Praxis (Bern 1994) (2006) 0.78
Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value. Digestion (2002) 0.78
Prevalence of the -295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis. Clin Exp Immunol (2005) 0.77
Comparison of inflammatory bowel disease at younger and older age. Eur J Med Res (2004) 0.77
Serum p53 antibodies in patients with chronic inflammatory bowel disease. Gut (1998) 0.77
Complete regression of advanced HCC with long acting octreotide. Gut (2003) 0.77
Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection. Z Gastroenterol (2000) 0.77
Serum antibodies in first-degree relatives of patients with IBD: a marker of disease susceptibility? A follow-up pilot-study after 7 years. Digestion (2005) 0.77
No significant association between mutations in exons 6 and 8 of the autoimmune regulator (AIRE) gene and inflammatory bowel disease. Eur J Immunogenet (2004) 0.77
Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clin Immunol (2001) 0.77
Methotrexate in ulcerative colitis. Aliment Pharmacol Ther (2003) 0.77
A score card for upper GI endoscopy: Evaluation of interobserver variability in examiners with various levels of experience. Z Gastroenterol (2002) 0.77
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest (1998) 0.76
Medical approaches and future options in chronic active ulcerative colitis. Int J Colorectal Dis (2004) 0.76
Improved ultrasound examination of pancreas grafts in type 1 (insulin-dependent) diabetic patients using tissue harmonic imaging. Transplant Proc (2003) 0.75
Factor V Leiden mutation in patients with inflammatory bowel disease. Gastroenterology (1999) 0.75
Heparin therapy for ulcerative colitis. Gastroenterology (2001) 0.75
Clozapine and sudden death. Lancet (2000) 0.75
A645G (Lys216Glu) polymorphism of the bactericidal/permeability-increasing protein gene in periodontal disease. Int J Immunogenet (2006) 0.75
[Solitary carcinoma metastasis in Paget's disease. Distinction from sarcomatous changes (author's transl)]. Arch Orthop Trauma Surg (1980) 0.75
Peptide YY release in anorectic patients after liquid meal. Appetite (2006) 0.75
[What is Crohn's disease?]. Internist (Berl) (2007) 0.75
[From fecal occult blood testing to Genoccult?]. Z Gastroenterol (2003) 0.75
Pancreatic autoantibodies in Crohn's disease: a feasible diagnostic tool? Eur J Gastroenterol Hepatol (2005) 0.75
[Viscerocutaneous hemangiomatosis--the so-called blue-rubber-bleb nevus syndrome]. Hautarzt (1991) 0.75
Ulcerating proctitis in a patient with congenital neutropenia. Am J Gastroenterol (2003) 0.75
[Hepatitis of unknown origin with protracted liver failure in a 48-year-old patient with significantly increased pANCA titer]. Internist (Berl) (2003) 0.75
[Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders]. Laryngorhinootologie (2003) 0.75
[Duodenosigmoidal fistula in a patient with Crohn's disease]. Zentralbl Chir (2001) 0.75
[Grading of clinical findings and stage classification in gastroenterology and hepatology]. Internist (Berl) (1992) 0.75
Closure of an enterocutaneous fistula by high dose intravenous immune globuline therapy in a patient with X-linked agammaglobulinemia. Am J Gastroenterol (2001) 0.75
[Osteomyelitis sicca in Crohn disease--coincidence or extraintestinal manifestation?]. Z Gastroenterol (1996) 0.75
[Compliance with terminology standards in reflux, ulcers, and gastritis: A study of 881 consecutive upper gastrointestinal endoscopy reports]. Z Gastroenterol (2001) 0.75
Systemic levels of soluble CD44 variant 6 (sCD44v6) in chronic inflammatory bowel disease. Am J Gastroenterol (1996) 0.75
[Hematochezia]. MMW Fortschr Med (2004) 0.75
Gastric outlet obstruction and pulmonary infiltrate in a patient with Crohn's disease: successful treatment by Billroth-II-resection. Z Gastroenterol (2000) 0.75
[Chronic diarrhea after a journey to Sri Lanka]. Z Gastroenterol (2002) 0.75
Are guidelines followed in Helicobacter pylori diagnosis and therapy? An inquiry among gastroenterologists, referring physicians and patients in Munich. Z Gastroenterol (2000) 0.75
[Complicated ulcerative colitis]. Z Gastroenterol (2003) 0.75